| 1. |
- Al Musawi, Ahmed, et al.
(författare)
-
Intervention for a correct medication list and medication use in older adults : a non-randomised feasibility study among inpatients and residents during care transitions
- 2024
-
Ingår i: International Journal of Clinical Pharmacy. - : Springer. - 2210-7703 .- 2210-7711.
-
Tidskriftsartikel (refereegranskat)abstract
- BackgroundMedication discrepancies in care transitions and medication non-adherence are problematic. Few interventions consider the entire process, from the hospital to the patient's medication use at home.AimIn preparation for randomised controlled trials (RCTs), this study aimed (1) to investigate the feasibility of recruitment and retention of patients, and data collection to reduce medication discrepancies at discharge and improve medication adherence, and (2) to explore the outcomes of the interventions.MethodParticipants were recruited from a hospital and a residential area. Hospital patients participated in a pharmacist-led intervention to establish a correct medication list upon discharge and a follow-up interview two weeks post-discharge. All participants received a person-centred adherence intervention for three to six months. Discrepancies in the medication lists, the Beliefs about Medicines Questionnaire (BMQ-S), and the Medication Adherence Report Scale (MARS-5) were assessed.ResultsOf 87 asked to participate, 35 were included, and 12 completed the study. Identifying discrepancies, discussing discrepancies with physicians, and performing follow-up interviews were possible. Conducting the adherence intervention was also possible using individual health plans for medication use. Among the seven hospital patients, 24 discrepancies were found. Discharging physicians agreed that all discrepancies were errors, but only ten were corrected in the discharge information. Ten participants decreased their total BMQ-S concern scores, and seven increased their total MARS-5 scores.ConclusionBased on this study, conducting the two RCTs separately may increase the inclusion rate. Data collection was feasible. Both interventions were feasible in many aspects but need to be optimised in upcoming RCTs.
|
|
| 2. |
|
|
| 3. |
-
Farmakologi och farmakoterapi
- 2023. - 1:1
-
Samlingsverk (redaktörskap) (populärvet., debatt m.m.)abstract
- Ordination av läkemedel börjar oftast hos en läkare och då inleds en komplex process där flera olika professioner, framför allt sjuksköterskor och farmaceuter, bidrar med sin kompetens till en helhetssyn för att optimera läkemedelsbehandling. Detta är fokus i denna bok, Farmakologi och farmakoterapi. Här presenteras den teoretiska bakgrunden som ger förståelse i hur läkemedel omsätts och fungerar i kroppen, men även farmakoterapi (läkemedelsbehandling) och vanliga läkemedelsrelaterade problem beskrivs. Boken är uppdelad i tre delar. Den första delen beskriver olika aspekter på praktisk läkemedelsanvändning i vården och av patienten. Speciellt fokus läggs på utvärdering av läkemedelsbehandling och samarbete mellan vårdens olika professioner. Den andra delen beskriver basalfarmakologiska principer och tillämpningar där teori och praktiska utföranden varvas. Del tre är uppbyggd enligt ATC-systemet och fokuserar på farmakoterapi vid olika sjukdomstillstånd där rekommendationer samt nytta och eventuella risker med läkemedel beskrivs. Boken vänder sig till studenter på sjuksköterskeprogrammet och till yrkesverksamma sjuksköterskor. Den kan även användas av andra professioner inom hälso- och sjukvården, såväl i undervisning som i informationssökande.
|
|
| 4. |
|
|
| 5. |
|
|
| 6. |
- Stollenwerk, Maria Magdalena, 1959-, et al.
(författare)
-
Core competencies for a biomedical laboratory scientist - a Delphi study
- 2022
-
Ingår i: BMC Medical Education. - : BMC. - 1472-6920. ; 22:1
-
Tidskriftsartikel (refereegranskat)abstract
- Background After completing university education, biomedical laboratory scientists work in clinical laboratories, in biomedical research laboratories, in biotech, and in pharmaceutical companies. Laboratory diagnostics have undergone rapid development over the recent years, with the pace showing no signs of abatement. This rapid development challenges the competence of the staff and will most certainly influence the education of future staff. This study aimed to examine what was considered the necessary competencies needed to pursue a career as a biomedical laboratory scientist. Methods A modified Delphi technique was used, with the panel of experts expressing their views in a series of three questionnaire. Consensus was defined as the point which 75 % or more of the panel participants agreed that a particular competency was necessary. Results The study highlights the perceived importance of mostly generic competencies that relate to quality, quality assurance, and accuracy, as well as different aspects of safety, respect, trustworthiness (towards patients/clients and colleagues), and communication skills. The results also stress the significance of self-awareness and professionality. Conclusions We identified important competencies for biomedical laboratory scientists. Together with complementary information from other sources, i.e., guidelines, laws, and scientific publications, the competencies identified can be used as learning outcomes in a competency-based education to provide students with all the competencies needed to work as professional biomedical laboratory scientists.
|
|
| 7. |
- Östbring, M. J., et al.
(författare)
-
A pharmaceutical care intervention increased adherence seemingly through an effect on beliefs about medicines
- 2022
-
Ingår i: International Journal of Clinical Pharmacy. - : Springer. - 2210-7703 .- 2210-7711. ; 44:1, s. 293-294
-
Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)abstract
- Introduction: Beliefs about medicines is one of the strongest determinants of adherence. It’s plausible that adherence interventions can be effective by changing patients’ beliefs about medicines.Aim: To describe how a pharmaceutical care intervention affected beliefs about medicines and adherence.Methods: In the Motivational Interviewing and Medication review in Coronary heart disease (MIMeRiC) trial, 316 patients were randomized to a pharmaceutical care intervention during around 6 months, or standard care. Key secondary outcome was a combination of persistence (at least one refill in the period 12–16 months) and a self-report instrument at 15 months. Beliefs about medicines specific (BMQ-S) was used as a process measure.Results: At follow up, 88% and 77% (P = 0.033) of patients were adherent in the intervention and control group respectively. Patients who had received the intervention had a more positive necessity–concern differential (NCD) than patients with standard care, 7.9 (5.7) vs. 6.3 (5.8); P = 0.022. Patients in the intervention group who were adherent had a mean NCD of 8.8 (5.6), while intervention patients who were not adherent had mean NCD 5.4 (5.5); P = 0.046. In patients receiving standard care, the mean NCD was 6.7 (5.5) and 6.3 (5.9); P = 0.746 among patients who were adherent and not adherent at follow-up.Conclusion: The intervention seemed to increase adherence through an effect on patients’ medication beliefs.
|
|
| 8. |
- Eriksson, Tommy, 1961-, et al.
(författare)
-
Clinical pharmacists’ services, role and acceptance : a national Swedish survey
- 2021
-
Ingår i: European journal of hospital pharmacy. Science and practice. - : BMJ Publishing Group Ltd. - 2047-9956 .- 2047-9964. ; 28:e1
-
Tidskriftsartikel (refereegranskat)abstract
- Aim: Describe, and between regions, compare the services provided, and the pharmacists’ perceptions of their role and its importance.Method: Online survey involving active clinical pharmacists in Sweden.Result: The survey was completed by 118 pharmacists (66%), half of whom had at least 1 year’s formal training in clinical pharmacy, and work experience in excess of 5 years. Admission medication reconciliation and medication review are provided in most regions and often on a daily basis. The most important services were: making suggestions to physicians regarding drug changes, medication review, medication reconciliation, and patient communication. On a five-point Likert-scale (where 1 = negative and 5 = positive) very few respondents scored less than 4 on the role, acceptance and skills questions.Discussion: Our study confirms the strong position of clinical pharmacy and clinical pharmacists in Sweden. There were some differences regarding the services provided between regions but clinical pharmacists’ patient-centred work in the clinical setting as part of the care team is well established, accepted and important. Respondents believed they could take on additional responsibilities for prescription changes without the need for further education.Conclusion: Patient-centred clinical pharmacy work in a clinical setting as part of the care team is well established, accepted and important.
|
|
| 9. |
- Eriksson, Tommy, Professor, 1961-
(författare)
-
The CLEO assessment tool for pharmacist interventions.
- 2021
-
Ingår i: European journal of hospital pharmacy. Science and practice. - : BMJ Publishing Group Ltd. - 2047-9956 .- 2047-9964. ; 28:4
-
Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)
|
|
| 10. |
- Hellström, Lina, 1975-, et al.
(författare)
-
Prospective observational study of medication reviews in internal medicine wards : evaluation of drug-related problems
- 2021
-
Ingår i: European journal of hospital pharmacy. Science and practice. - : BMJ Publishing Group Ltd. - 2047-9956 .- 2047-9964. ; 28:e1
-
Tidskriftsartikel (refereegranskat)abstract
- BACKGROUND: The Lund Integrated Medicines Management model offers a systematic approach for individualising and optimising patient drug treatment. Clinical, economical and humanistic outcomes have been shown as well as results from the medication reconciliation process. There is a need also to describe the medication review process.OBJECTIVE: To describe the frequency and types of drug-related problems (DRPs) identified during medication reviews and to evaluate the actions of the pharmacists and the physicians regarding the identified DRPs.METHOD: Structured medication reviews were conducted by a multi-professional team on top of standard care for 719 patients in two internal medicine wards in a Swedish University Hospital. The medication reviews were studied retrospectively to classify DRPs and actions taken.RESULTS: A total of 573 (80%) of patients had at least one actual DRP; an average of three DRPs per patient and in total 2164. Wrong drug and adverse drug reaction were the most common types of DRPs. The most frequent medication groups involved in DRPs were drugs for the cardiovascular system and the nervous system and the most frequent substances were warfarin, digoxin, furosemide and paracetamol. The 10 most common medications accounted for 27% of the actual DRPs. Of the identified DRPs, a total of 1740 (80%) were acted on. The three most common types of adjustments made were withdrawal of drug therapy, change of drug therapy and initiation of drug therapy. When the pharmacist suggested an adjustment, the physician implemented 88% (1037/1174) of the recommendations.CONCLUSION: DRPs are common among elderly patients who are admitted to hospital. Systematic identification of high-risk medications and common DRP types enables targeting of prioritised patients for medication reviews.
|
|
